|1.||Miller, Steven L: 1 article (11/2014)|
|2.||Apland, James P: 1 article (11/2014)|
|3.||Rossetti, Franco: 1 article (11/2014)|
|4.||Braga, Maria F M: 1 article (11/2014)|
|5.||Figueiredo, Taiza H: 1 article (11/2014)|
|6.||Aroniadou-Anderjaska, Vassiliki: 1 article (11/2014)|
|7.||Aroniadou-Anderjaska, V: 1 article (03/2009)|
|8.||Apland, J P: 1 article (03/2009)|
|9.||Braga, M F M: 1 article (03/2009)|
03/03/2009 - "The GluR5KR antagonist UBP302 reduced the amplitude of the hippocampal interictal-like spikes, and eliminated the seizure-like discharges in the BLA, or reduced their duration and frequency, with no significant effect on the evoked field potentials. "
11/01/2014 - "The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302."
11/01/2014 - "Here, we compared the efficacy of DZP with that of UBP302 [(S)-3-(2-carboxybenzyl)willardiine; an antagonist of the kainate receptors that contain the GluK1 subunit] against seizures, neuropathology, and behavioral deficits induced by soman in rats. "
|1.||Kainic Acid Receptors (Kainate Receptor)